Review: modulating factors in amyloid-beta fibril formation
- PMID: 10940230
- DOI: 10.1006/jsbi.2000.4289
Review: modulating factors in amyloid-beta fibril formation
Abstract
Amyloid formation is a key pathological feature of Alzheimer's disease and is considered to be a major contributing factor to neurodegeneration and clinical dementia. Amyloid is found as both diffuse and senile plaques in the parenchyma of the brain and is composed primarily of the 40- to 42-residue amyloid-beta (Abeta) peptides. The characteristic amyloid fiber exhibits a high beta-sheet content and may be generated in vitro by the nucleation-dependent self-association of the Abeta peptide and an associated conformational transition from random to beta-conformation. Growth of the fibrils occurs by assembly of the Abeta seeds into intermediate protofibrils, which in turn self-associate to form mature fibers. This multistep process may be influenced at various stages by factors that either promote or inhibit Abeta fiber formation and aggregation. Identification of these factors and understanding the driving forces behind these interactions as well as the structural motifs necessary for these interactions will help to elucidate potential sites that may be targeted to prevent amyloid formation and its associated toxicity. This review will discuss some of the modulating factors that have been identified to date and their role in fibrillogenesis.
Copyright 2000 Academic Press.
Similar articles
-
Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.Acc Chem Res. 2008 Oct;41(10):1309-18. doi: 10.1021/ar8000475. Acc Chem Res. 2008. PMID: 18937396
-
Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.J Mol Biol. 1994 Nov 18;244(1):64-73. doi: 10.1006/jmbi.1994.1704. J Mol Biol. 1994. PMID: 7966323
-
Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers.Biochemistry. 2005 Jan 11;44(1):165-73. doi: 10.1021/bi048846t. Biochemistry. 2005. PMID: 15628857
-
Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.Acta Biochim Pol. 2005;52(2):417-23. Epub 2005 May 31. Acta Biochim Pol. 2005. PMID: 15933761 Review.
-
Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.Microsc Res Tech. 2005 Jul;67(3-4):164-74. doi: 10.1002/jemt.20189. Microsc Res Tech. 2005. PMID: 16103999 Review.
Cited by
-
Weak glycolipid binding of a microdomain-tracer peptide correlates with aggregation and slow diffusion on cell membranes.PLoS One. 2012;7(12):e51222. doi: 10.1371/journal.pone.0051222. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251459 Free PMC article.
-
Common Factors of Alzheimer's Disease and Rheumatoid Arthritis-Pathomechanism and Treatment.Molecules. 2021 Oct 5;26(19):6038. doi: 10.3390/molecules26196038. Molecules. 2021. PMID: 34641582 Free PMC article. Review.
-
Aβ1-25-Derived Sphingolipid-Domain Tracer Peptide SBD Interacts with Membrane Ganglioside Clusters via a Coil-Helix-Coil Motif.Int J Mol Sci. 2015 Nov 3;16(11):26318-32. doi: 10.3390/ijms161125955. Int J Mol Sci. 2015. PMID: 26540054 Free PMC article.
-
Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes.Int J Alzheimers Dis. 2011 Mar 17;2011:134971. doi: 10.4061/2011/134971. Int J Alzheimers Dis. 2011. PMID: 21547213 Free PMC article.
-
Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells.Antimicrob Agents Chemother. 2002 Aug;46(8):2619-26. doi: 10.1128/AAC.46.8.2619-2626.2002. Antimicrob Agents Chemother. 2002. PMID: 12121942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources